• Follow the Money: $100M to DNAnexus, Investments in Machine-Learning for Drug Discovery, More

    Bio-IT World   Big investments this past month in machine-learning driven drug discovery from insitro, and DNAnexus’s and cloud-based informatics platform. Vaccine funding for GreenLight Biosciences, boron drug delivery, and more of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.  

    Jun 17, 2020
  • NIH Launches Centralized National Enclave For COVID-19 Patient Data

    Bio-IT World The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country. It is part of an effort, called the National COVID Cohort Collaborative (N3C), to help scientists analyze these data to understand the disease and develop treatments. This effort aims to transform clinical information into knowledge urgently needed to study COVID-19, including health risk factors that indicate better or worse outcomes of the disease, and identify potentially effective treatments.

    Jun 15, 2020
  • The Pistoia Alliance Launches Toolkit, Accelerates Implementation of FAIR Data Principles

    Bio-IT World   The Pistoia Alliance has launched a freely accessible toolkit to help companies implement the FAIR (Findable, Accessible, Interoperable, Reusable) guiding principles for data management and stewardship. The project was funded by pharmaceutical and biotech companies including AstraZeneca, Bayer, Roche, Novartis, Bristol-Myers Squibb, and AbbVie.

    Jun 15, 2020
  • COVID-19’s Achilles’ Heel, Other News From the Bio-IT Community

    Bio-IT World | The Bio-IT community is continuing to adapt to their newfound role in the fight against the COVID-19 virus. Recent updates include recent collaborations between organizations and universities, innovative modeling tools, and the discovery that the virus’ main protease may wind up being its Achilles’ heel.

    Jun 12, 2020
  • MilliporeSigma, 10x Genomics Launch New Option For CRISPR Research

    Bio-IT World News Brief | MilliporeSigma and 10x Genomics announced that they have developed a new option for biological experiments. The collaboration provides a linking of two innovative technologies: single cell transcriptomics and pooled CRISPR screening.

    Jun 10, 2020